Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.52 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.52 |
| ▸ | CES2 | O00748 | 1/20 | 0.52 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.46 |
| ▸ | IDO1 | P14902 | 2/20 | 0.46 |
| ▸ | KIF11 | P52732 | 1/20 | 0.46 |
| ▸ | BACE1 | P56817 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | P2RX1 | P51575 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.40 |
| ▸ | ITGAV | P06756 | 1/20 | 0.40 |
| ▸ | RXRA | P19793 | 1/20 | 0.40 |
| ▸ | RXRB | P28702 | 1/20 | 0.40 |
| ▸ | RXRG | P48443 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29886876 | 0.97 | CES2 (0.56) | GABRA1GABRB2CES2PTGS1IDO1 | |
| Water SCHEMBL21493255 | 0.97 | GABRA1 (0.50) | GABRA1GABRB2CES2PTGS1IDO1 | |
| SCHEMBL29005991 | 0.97 | GABRA1 (0.50) | GABRA1GABRB2CES2PTGS1IDO1 | |
| SCHEMBL29384937 | 0.97 | GABRA1 (0.50) | GABRA1GABRB2CES2PTGS1IDO1 | |
| SCHEMBL29170632 | 0.94 | CES2 (0.48) | GABRA1GABRB2CES2PTGS1IDO1 | |
| SCHEMBL69029 | 0.94 | PTGS1 (0.52) | GABRA1GABRB2CES2PTGS1IDO1 | |
| SCHEMBL27436296 | 0.89 | CES2 (0.44) | GABRA1GABRB2CES2PTGS1IDO1 | |
| SCHEMBL17048684 | 0.87 | GABRA1 (0.54) | GABRA1GABRB2CES2PTGS1IDO1 | |
| SCHEMBL18353568 | 0.87 | GABRA1 (0.76) | GABRA1GABRB2CES2PTGS1IDO1 | |
| Cyanate SCHEMBL30681205 | 0.87 | CES2 (0.43) | GABRA1GABRB2CES2PTGS1IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1040 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3842468-B1 | LIQUID CRYSTAL POLYESTER RESIN FOR LAMINATE, LIQUID CRYSTAL POLYESTER RESIN COMPOSITION, LAMINATE, AND LIQUID CRYSTAL POLYESTER RESIN FILM | TORAY INDUSTRIES (JP) | 2025-10-15 | — | — | EP | claimed |
| US-12410138-B2 | Process comprising the use of new iridium catalysts for enantioselective hydrogenation of 4-substituted 1,2-dihydroquinolines | BAYER AKTIENGESELLSCHAFT (DE) | 2025-09-09 | — | — | US | claimed |
| CN-120157864-A | Multi-center metalloporphyrin complex and application thereof in preparing polycarbonate through catalysis | 烟台大学 | 2025-06-17 | — | — | CN | claimed |
| CN-120024103-A | Transparent polycarbonate composite board with high flame retardance, high weather resistance and self-cleaning function and preparation method thereof | 上海品诚控股集团有限公司 | 2025-05-23 | — | — | CN | claimed |
| CN-119804835-A | Static color development testing method for thermosensitive paper | 沈阳感光化工研究院有限公司 | 2025-04-11 | — | — | CN | claimed |
| CN-119798271-A | Fluorine-containing fluorane compound, light-resistant thermosensitive dye, preparation method and application | 沈阳感光化工研究院有限公司 | 2025-04-11 | — | — | CN | claimed |
| CN-119592003-A | Low-dielectric high-flame-retardance cable material and preparation method and application thereof | 宁波聚泰新材料科技有限公司 | 2025-03-11 | — | — | CN | claimed |
| CN-119409731-A | Binuclear alkali metal complex and preparation method and application thereof | 中山大学 | 2025-02-11 | — | — | CN | claimed |
| WO-2025021733-A1 | ENANTIOSELECTIVE HYDROGENATION OF 4-SUBSTITUTED 1,2-DIHYDROQUINOLINES IN THE PRESENCE OF A CHIRAL IRIDIUM (P,S)-LIGAND CATALYST | BAYER AKTIENGESELLSCHAFT (DE) | 2025-01-30 | — | — | WO | claimed |
| CN-119264394-A | Method for preparing polyhydroxyalkanoate copolymer by catalyzing cyclopropylium salt catalyst | 浙江大学 | 2025-01-07 | — | — | CN | claimed |
| EP-1465869-A4 | MODULATORS OF LXR | X CEPTOR THERAPEUTICS INC (US) | 2005-12-28 | — | — | EP | claimed |
| JP-2005536450-A | — | — | 2005-12-02 | — | — | JP | claimed |
| CN-1560111-A | Preparation process of polyester carbonate with high molecular weight whole alternant structure | 大连理工大学 | 2005-01-05 | — | — | CN | claimed |
| EP-1465869-A1 | MODULATORS OF LXR | X-Ceptor Therapeutics, Inc. (US) | 2004-10-13 | — | — | EP | claimed |
| US-20030181420-A1 | Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors | EXELIXIS, INC. | 2003-09-25 | — | — | US | claimed |
| WO-2003059884-A1 | MODULATORS OF LXR | X-CEPTOR THERAPEUTICS, INC. (US) | 2003-07-24 | — | — | WO | claimed |
| US-4960539-A | Use of fluoromethylphenols as solvents for LC-polymers, and new fluoromethylphenols | BAYER AKTIENGESELLSCHAFT (DE) | 1990-10-02 | — | — | US | claimed |
| EP-0286953-B1 | USE OF FLUOROMETHYL PHENOLS AS SOLVENTS FOR LC POLYMERS, AND FLUOROMETHYL PHENOLS | BAYER AG (DE) | 1990-09-26 | — | — | EP | claimed |
| EP-0088066-B1 | 3,5-BIS (TRIFLUOROMETHYL) PHENOXY CARBOXYLIC ACIDS AND DERIVATIVES THEREOF | MONSANTO COMPANY (US) | 1985-04-03 | — | — | EP | claimed |
| EP-0088066-A1 | 3,5-Bis (trifluoromethyl) phenoxy carboxylic acids and derivatives thereof | MONSANTO COMPANY (US) | 1983-09-07 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030181420-A1 | Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors | NR1H2, NR1H3, NCOA1 | GABRA1 534/4885GABRB2 749/4885CES2 1566/4885 |
| US-12410138-B2 | Process comprising the use of new iridium catalysts for enantioselective hydrogenation of 4-substituted 1,2-dihydroquinolines | HVCN1, HDHD5, HRH4 | GABRA1 3037/4885GABRB2 2404/4885CES2 3681/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.